Appendix: Investigating the Power of Placebo

Beecher, H. K. (1955). "The powerful placebo". Journal of the American Medical Association 159 (17): 1602–1606. doi:10.1001/jama.1955.02960340022006

Hróbjartsson A, Gøtzsche PC (2001). "Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment". New England Journal of Medicine 344 (21): 1594–1602. doi:10.1056/NEJM200105243442106. PMID 11372012.

Hróbjartsson A, Gøtzsche PC (2010). "Placebo interventions for all clinical conditions". In Hróbjartsson, Asbjørn. Cochrane Database Syst Rev 106 (1): CD003974. doi:10.1002/14651858.CD003974.pub3.

Moerman DE, Jonas WB (2002). "Deconstructing the placebo effect and finding the meaning response". Ann Intern Med. 136 (6): 471–6

Talbot M The Placebo Prescription New York Times Jan 9, 2000

Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002 Jul 11;347(2):81-8.

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2). Retrieved from http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050045

Fournier J. C., DeRubeis R. J., Hollon S. D., Dimidjian S., Amsterdam J. D., Shelton R. C. et al. (2010). "Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis". Journal of the American Medical Association 303 (1): 47–53.

Colloca L, Benedetti F (2009). "Placebo analgesia induced by social observational learning". Pain 144 (1–2): 28–34. doi:10.1016/j.pain.2009.01.033

Levine, J. D.; Gordon, N. C.; Bornstein, J. C.; Fields, H. L. (1979). "Role of pain in placebo analgesia". Proceedings of the National Academy of Sciences of the United States of America 76 (7): 3528–3531. doi:10.1073/pnas.76.7.3528

de la Fuente-Fernández R, Stoessl AJ.The placebo effect in Parkinson's disease. Trends Neurosci. 2002 Jun;25(6):302-6.

Moerman DE, Jonas WB (2002). "Deconstructing the placebo effect and finding the meaning response". Ann Intern Med. 136 (6): 471–6.

Cho HJ, Hotopf M, Wessely S.The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Psychosom Med. 2005 Mar-Apr;67(2):301-13.

Meissner K, Distel H, Mitzdorf Evidence for placebo effects on physical but not biochemical parameters: a review of clinical trials BMC Medicine 2007 5:3 doi: 10.1186/1741-7015-5-3

Whalley B, Hyland ME, Kirsch I (2008). "Consistency of the placebo effect". J Psychosom Res 64 (5): 537–41. doi:10.1016/j.jpsychores.2007.11.007. PMID 18440407.

Oken BS (2008). "Placebo effects: clinical aspects and neurobiology". Brain 131 (Pt 11): 2812–23. doi:10.1093/brain/awn116. PMC 2725026. PMID 18567924.

Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008). "Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses". Arch Gen Psychiatry 65 (2): 220–31.

Qiu YH, Wu XY, Xu H, Sackett D. Neuroimaging study of placebo analgesia in humans. Neurosci Bull. 2009 Oct;25(5):277-82. doi: 10.1007/s12264-009-0907-2.

Lidstone SC, Stoessl AJ (2007). "Understanding the placebo effect: contributions from neuroimaging". Mol Imaging Biol 9 (4): 176–85. doi:10.1007/s11307-007-0086-3. PMID 17334853.

Goffaux P, Redmond WJ, Rainville P, Marchand S (2007). "Descending analgesia--when the spine echoes what the brain expects". Pain 130 (1–2): 137–43. doi:10.1016/j.pain.2006.11.011. PMID 17215080.

Matre D, Casey KL, Knardahl S (2006). "Placebo-induced changes in spinal cord pain processing". J Neurosci 26 (2): 559–63

Pollo A, Carlino E, Benedetti F. Placebo mechanisms across different conditions: from the clinical setting to physical performance. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1790-8. doi: 10.1098/rstb.2010.0381.

Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., Rainero I. 2003. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J. Neurosci. 23, 4315–4323.

Stockhorst U., Steingruber H. J., Scherbaum W. A. 2000. Classically conditioned responses following repeated insulin and glucose administration in humans. Behav. Brain Res. 110, 143–159

Sabbioni M. E. E., Bovbjerg D. H., Mathew S., Sikes C., Lasley B., Stokes P. E. 1997. Classically conditioned changes in plasma cortisol levels induced by dexamethasone in healthy men. FASEB J. 11, 1291–1296.

Giang D. W., Goodman A. D., Schiffer R. B., Mattson D. H., Petrie M., Cohen N., Ader R. 1996. Conditioning of cyclophosphamide-induced leukopenia in humans. J. Neuropsychiatry Clin. Neurosci. 8, 194–201.

Goebel M. U., et al. 2002. Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16, 1869–1873

Vits S., Cesko E., Enck P., Hillen U., Schadendorf D., Schedlowski M. 2011. Behavioral conditioning as the mediator of placebo responses in the immune system. Phil. Trans. R. Soc. B 366, 1799–1807 (doi:10.1098/rstb.2010.0392) doi: 10.1098/rstb.2010.0392. [PMC free article] [PubMed] [Cross Ref]

Schedlowski M., Pacheco-López G. 2010. The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24, 176–185

Benedetti F, Carlino E, Pollo A How placebos change the patient's brain. Neuropsychopharmacology. 2011 Jan;36(1):339-54. doi: 10.1038/npp.2010.81. Epub 2010 Jun 30.

Waber RL, Shiv B, Carmon Z, Ariely D (2008). "Commercial features of placebo and therapeutic efficacy". JAMA 299 (9): 1016–7. doi:10.1001/jama.299.9.1016

Dolinska B (1999). "Empirical investigation into placebo effectiveness". Ir J Psych Med 16 (2): 57–58.

de Craen AJ, Roos PJ, Leonard de Vries A, Kleijnen J (1996). "Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness".

Colloca L, Benedetti F (2006). "How prior experience shapes placebo analgesia". Pain 124 (1–2): 126–33. doi:10.1016/j.pain.2006.04.005

Häuser W, Hansen E, Enck P. Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int. 2012 Jun;109(26):459-65. doi: 10.3238/arztebl.2012.0459. Epub 2012 Jun 29.

Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry. 2008 Feb;65(2):220-31. doi: 10.1001/archgenpsychiatry.2007.34.

Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007 Jun 29;147(2):260-71. Epub 2007 Mar 26.

Benedetti F, Amanzio M, Vighetti S, Asteggiano G The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci. 2006 Nov 15;26(46):12014-22.

Lown B Stuttgart: Schatteur; 2004. Die verlorene Kunst des Heilens